UMP Healthcare Holdings Ltd

Chart & Performance

D1W1MN

P/E

8.16

P/S

0.44

EPS

0.05

Div Yield, %

10.36%

Shrs. gr., 5y

1.13%

Rev. gr., 5y

5.70%

Revenues

748m

+2.85%

Net income

41m

-32.77%

CFO

145m

-23.51%

Dividend

Dec 10, 20240.02 HKD/sh

Profile

UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in two segments, Corporate Healthcare Solution Services and Clinical Healthcare Services. The company offers virtual care; family medicine; specialist consultation services, including internal medicine, surgery, pediatrics, cardiology, dermatology, otorhinolaryngology, orthopedics, ophthalmology, urology, gastroenterology and hepatology, radiology, endocrinology, and diabetes; and dental care services, such as dental implant, cosmetic dentistry, periodontal treatments, and orthodontics, as well as traditional Chinese medicines. It also provides physiotherapy services comprises muscle-strengthening, limb function, eye-hand coordination, and hand function trainings; day surgery and endoscopy; diagnostic imaging and laboratory; health assessment; visa medical examination; vaccination and consultation; vision care and optometry; plastic, head, and neck surgeries; dermatology and aesthetics; chronic disease management; and COVID-19 screening test services. In addition, the company engages in the provision of healthcare training and consultation services. It serves insurance companies and corporations, and self-paid patients. The company operates a network of approximately 1,100 self-owned and affiliated service points. UMP Healthcare Holdings Limited was founded in 1990 and is headquartered in Central, Hong Kong.

URL

https://www2.ump.com.hk/

IPO date

Nov 27, 2015

Employees

421

Domiciled in

Incorporated in

Valuation

Order:

Title HKD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title HKD in thousands, except ratios and share amounts	2024‑06	2023‑06	2022‑06	2021‑06	2020‑06	2019‑06	2018‑06	2017‑06	2016‑06	2015‑06
Income
Revenues	748,489 2.85%	727,750 9.24%	666,201 7.95%
Cost of revenue	325,635	494,507	451,362
Unusual Expense (Income)
NOPBT	422,854	233,243	214,839
NOPBT Margin	56.49%	32.05%	32.25%
Operating Taxes	5,407	8,630	11,946
Tax Rate	1.28%	3.70%	5.56%
NOPAT	417,447	224,613	202,893
Net income	40,643 -32.77%	60,452 -16.23%	72,168 -2.31%
Dividends	(34,367)	(23,108)	(22,041)
Dividend yield	8.27%	3.80%	3.80%
Proceeds from repurchase of equity	(463)	(5,074)	(314)
BB yield	0.11%	0.83%	0.05%
Debt
Debt current	105,336	58,483	63,272
Long-term debt	187,928	129,864	170,138
Deferred revenue
Other long-term liabilities	7,303	6,309	7,441
Net debt	(3,486)	(207,863)	(122,513)
Cash flow
Cash from operating activities	145,353	190,041	110,912
CAPEX	(57,245)	(109,334)	(84,515)
Cash from investing activities	(70,575)	(134,088)	(77,121)
Cash from financing activities	(117,128)	(53,672)	(90,980)
FCF	366,255	227,128	59,999
Balance
Cash	297,273	334,625	291,646
Long term investments	(523)	61,585	64,277
Excess cash	259,326	359,822	322,613
Stockholders' equity	323,366	351,619	331,904
Invested Capital	664,821	528,844	544,736
ROIC	69.94%	41.84%	40.98%
ROCE	44.92%	26.22%	24.40%
EV
Common stock shares outstanding	799,485	789,955	772,788
Price	0.52 -32.47%	0.77 2.67%	0.75 -19.35%
Market cap	415,732 -31.65%	608,266 4.95%	579,591 -18.10%
EV	430,579	429,575	495,730
EBITDA	536,640	337,128	297,668
EV/EBITDA	0.80	1.27	1.67
Interest	6,944	5,675	3,918
Interest/NOPBT	1.64%	2.43%	1.82%